Lathrop Investment Management’s AbbVie ABBV Stock Holding History

Lathrop Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Hold	4,355	–	–	0.19%	51
2026 Q1	$947K	Hold	4,355	–	–	0.18%	51
2025 Q4	$995K	Buy	4,355 +67	+2%	+$15.3K	0.18%	49
2025 Q3	$993K	Buy	4,288 +15	+0.4%	+$3.06K	0.18%	48
2025 Q2	$793K	Hold	4,273	–	–	0.15%	52
2025 Q1	$895K	Hold	4,273	–	–	0.18%	53
2024 Q4	$759K	Hold	4,273	–	–	0.14%	57
2024 Q3	$844K	Buy	4,273 +500	+13%	+$93.3K	0.16%	53
2024 Q2	$647K	Hold	3,773	–	–	0.13%	55
2024 Q1	$687K	Hold	3,773	–	–	0.13%	52
2023 Q4	$585K	Hold	3,773	–	–	0.12%	52
2023 Q3	$562K	Hold	3,773	–	–	0.12%	52
2023 Q2	$508K	Hold	3,773	–	–	0.1%	55
2023 Q1	$601K	Sell	3,773 -415	-10%	-$63.4K	0.13%	51
2022 Q4	$677K	Buy	4,188 +415	+11%	+$63.6K	0.15%	49
2022 Q3	$506K	Hold	3,773	–	–	0.13%	49
2022 Q2	$578K	Hold	3,773	–	–	0.14%	47
2022 Q1	$612K	Hold	3,773	–	–	0.13%	47
2021 Q4	$511K	Hold	3,773	–	–	0.1%	50
2021 Q3	$407K	Hold	3,773	–	–	0.09%	52
2021 Q2	$425K	Hold	3,773	–	–	0.09%	51
2021 Q1	$408K	Sell	3,773 -114	-3%	-$12.2K	0.09%	51
2020 Q4	$416K	Buy	3,887 +339	+10%	+$32.6K	0.1%	53
2020 Q3	$311K	Sell	3,548 -100	-3%	-$9.41K	0.09%	59
2020 Q2	$358K	Sell	3,648 -235	-6%	-$20.7K	0.11%	54
2020 Q1	$296K	Sell	3,883 -3,162	-45%	-$269K	0.1%	56
2019 Q4	$624K	Sell	7,045 -3	-0%	-$249	0.17%	45
2019 Q3	$534K	Hold	7,048	–	–	0.15%	45
2019 Q2	$513K	Hold	7,048	–	–	0.15%	43
2019 Q1	$568K	Sell	7,048 -125	-2%	-$10.2K	0.17%	41
2018 Q4	$661K	Buy	7,173 +1,168	+19%	+$103K	0.23%	36
2018 Q3	$568K	Sell	6,005 -70	-1%	-$6.64K	0.15%	37
2018 Q2	$563K	Hold	6,075	–	–	0.15%	38
2018 Q1	$575K	Buy	6,075 +195	+3%	+$21.4K	0.16%	37
2017 Q4	$569K	Hold	5,880	–	–	0.16%	37
2017 Q3	$522K	Hold	5,880	–	–	0.15%	39
2017 Q2	$426K	Sell	5,880 -59	-1%	-$3.97K	0.12%	41
2017 Q1	$387K	Sell	5,939 -455	-7%	-$28.6K	0.11%	45
2016 Q4	$400K	Hold	6,394	–	–	0.12%	46
2016 Q3	$403K	Buy	6,394 +59	+0.9%	+$3.82K	0.12%	42
2016 Q2	$392K	Buy	6,335 +21	+0.3%	+$1.28K	0.12%	44
2016 Q1	$361K	Hold	6,314	–	–	0.11%	42
2015 Q4	$374K	Hold	6,314	–	–	0.12%	43
2015 Q3	$344K	Hold	6,314	–	–	0.12%	44
2015 Q2	$424K	Sell	6,314 -453	-7%	-$29.6K	0.14%	45
2015 Q1	$396K	Buy	6,767 +5	+0.1%	+$302	0.14%	45
2014 Q4	$443K	Buy	6,762 +7	+0.1%	+$441	0.16%	43
2014 Q3	$390K	Buy	6,755 +6	+0.1%	+$333	0.15%	43
2014 Q2	$381K	Buy	6,749 +6	+0.1%	+$315	0.14%	45
2014 Q1	$347K	Buy	6,743 +6	+0.1%	+$303	0.14%	45
2013 Q4	$356K	Hold	6,737	–	–	0.15%	46
2013 Q3	$301K	Buy	6,737 +54	+0.8%	+$2.39K	0.14%	42
2013 Q2	$276K	Buy	+6,683	New	+$292K	0.14%	42

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lathrop Investment Management's ABBV Position: Q2 2026 in Review

Lathrop Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 4,355 shares worth $1.1M. The position accounts for 0.19% of the portfolio, ranked #51.

Lathrop Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lathrop Investment Management held 4,355 shares of AbbVie worth $1.1M as of Q2 2026.
Lathrop Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.19% of Lathrop Investment Management's portfolio in Q2 2026, its #51 holding.
Lathrop Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lathrop Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.